Zydus Wellness Q3FY26: Net Sales Surge 113.7% to Rs 9,633mn with Strong EBITDA Growth

2 min read     Updated on 03 Feb 2026, 12:49 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Zydus Wellness delivered outstanding Q3FY26 performance with net sales jumping 113.7% to Rs 9,633 million and EBITDA growing 312.2% to Rs 610 million. The company maintained strong market leadership with Sugar Free at 96.3% market share, while successful integration of acquisitions like RiteBite and Comfort Click drove growth across wellness categories.

31648745

*this image is generated using AI for illustrative purposes only.

Zydus Wellness Limited reported exceptional financial performance for Q3FY26 ended December 31, 2025, with consolidated net sales surging 113.7% to Rs 9,633.00 million. The company's EBITDA grew by 312.2% year-on-year to Rs 610.00 million, reflecting strong operational performance driven by post-acquisition contributions from newly acquired businesses.

Financial Performance Overview

The company's robust top-line growth was primarily attributed to the integration of recently acquired businesses, particularly the Comfort Click acquisition. The strong performance demonstrates successful execution of the company's acquisition strategy and effective integration capabilities.

Financial Metric: Q3FY26 Performance
Net Sales: Rs 9,633.00 million
Net Sales Growth: 113.7% YoY
EBITDA: Rs 610.00 million
EBITDA Growth: 312.2% YoY

Brand Portfolio Strength

Zydus Wellness maintained strong market leadership across key categories. Sugar Free strengthened its dominance in the sugar substitute category with a market share of 96.3%, gaining 80 basis points year-on-year. The brand's D'Lite range, including cookies extended into multiple markets, continued witnessing strong growth, while Sugar Free Green registered sustained double-digit growth for 19 consecutive quarters.

Everyuth demonstrated strong category leadership with 48.5% share in scrubs and 76% in peel-off masks, ranking fifth in the facial cleansing segment with 7.9% share. Nycil maintained its number one position in prickly heat powder category with 33.1% market share.

Product Innovation and Expansion

The company expanded its product portfolio with strategic launches across brands. Nutralite delivered double-digit growth while maintaining leadership in the fat spread category, with Nutralite Professional launching Cheesy Delight and Slim Mayonnaise variants. Glucon-D retained leadership with 59% MAT market share, while Complan held fourth rank with 4.1% market share.

Brand Performance: Market Position
Sugar Free Market Share: 96.3%
Everyuth Scrubs Share: 48.5%
Nycil Market Share: 33.1%
Glucon-D Market Share: 59.0%

Acquisition Integration Success

RiteBite Max Protein business continued outperforming while maintaining leadership in protein snacking, improving EBITDA from breakeven at acquisition to near double-digit margins. The recently launched Wafer Bar contributed to category growth and market expansion.

Comfort Click strengthened its portfolio with four new gummy variants for adults, probiotic gummy for kids, and pure Himalayan shilajit resin. The WeightWorld brand advanced European expansion by entering Poland, Finland, and Portugal, strengthening Comfort Click's geographic footprint and reinforcing presence in high-growth wellness categories.

like15
dislike

Zydus Wellness Limited Schedules Board Meeting on February 3, 2026 for Q3FY26 Financial Results

1 min read     Updated on 21 Jan 2026, 04:43 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Zydus Wellness Limited has scheduled its Board of Directors meeting for February 3, 2026, to approve Q3FY26 unaudited financial results for the quarter and nine months ended December 31, 2025. The company has notified BSE and NSE in compliance with SEBI regulations, with trading window restrictions in place until February 5, 2026, for Directors and Designated Persons.

30539593

*this image is generated using AI for illustrative purposes only.

Zydus Wellness Limited has officially notified stock exchanges about its upcoming Board of Directors meeting scheduled for Tuesday, February 3, 2026. The meeting will focus on approving the company's unaudited financial results for the third quarter of fiscal year 2026, covering the quarter and nine months ended December 31, 2025.

Regulatory Compliance and Meeting Details

The company has issued formal notices to both BSE Limited and the National Stock Exchange of India Limited, adhering to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was signed by Nandish P. Joshi, Company Secretary & Compliance Officer, on January 21, 2026.

Parameter: Details
Meeting Date: Tuesday, February 3, 2026
Financial Period: Quarter and nine months ended December 31, 2025
BSE Code: 531335
NSE Symbol: ZYDUSWELL
Notification Date: January 21, 2026

Trading Window Restrictions

In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, Zydus Wellness has implemented a trading window closure for its Directors and Designated Persons. The restrictions will be effective until the financial results are made public.

Timeline: Status
Trading Window Closure: Until Thursday, February 5, 2026
Trading Resumption: Friday, February 6, 2026 onwards
Applicable To: All Directors and Designated Persons

Meeting Agenda

While the primary focus of the Board meeting will be the approval of Q3FY26 unaudited financial results, the company has indicated that other agenda items will also be considered during the session. The financial results will cover both the quarterly performance for the three months ended December 31, 2025, and the cumulative nine-month performance for the same period.

The scheduled Board meeting represents a routine corporate governance practice, ensuring timely disclosure of financial performance to stakeholders and maintaining transparency in line with regulatory requirements.

like15
dislike

More News on Zydus Wellness